A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma

By sjmartinez • March 7, 2025

Ellingson BM, Okobi Q, Chong R, Plawat R, Zhao E, Gafita A, Sonni I, Chun S, Filka E, Yao J, Telesca D, Li S, Li G, Lai A, Nghiemphu P, Czernin J, Nathanson DA, Cloughesy TF. A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma. Neurooncol Adv. 2025 Feb 19;7(1):vdaf022. doi: 10.1093/noajnl/vdaf022. PMID: 40051661; PMCID: PMC11883343.

Tags: Cardiology/Epi, EGFR, FDG PET, Glioblastoma, imaging biomarker, molecular imaging, Osimertinib, Publications

Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy

Li YR, Nan H, Liu Z, Fang Y, Zhu Y, Lyu Z, Shao Z, Zhu E, Zhang B, Yang Y, Shen X, Chen Y, Hsiai[...]

Pharmacologic Management of Ventricular Arrhythmias: Targeting Nicotinic Signaling Mechanisms

Ahluwalia N, Hanna P, Shivkumar K. Pharmacologic Management of Ventricular Arrhythmias: Targeting Nicotinic Signaling Mechanisms. J Am Coll Cardiol. 2026 Mar 10:S0735-1097(26)05234-4. doi: 10.1016/j.jacc.2026.01.084. Epub[...]

Echocardiography in HIV Disease

Durstenfeld MS, Kizer JR. Echocardiography in HIV Disease. Curr Cardiol Rep. 2026 Mar 18;28(1):34. doi: 10.1007/s11886-026-02353-9. PMID: 41848979.